Items | Screening/run-in period | Visit 1 (baseline) | Visit 2 | Visit 4 (endpoint) |
---|---|---|---|---|
Week of the trial | -1 | 0 | 4 | 8 |
Demographic information-taking | + | |||
Informed consent form | + | |||
General medical history-taking | + | |||
Photographing the patient’s face Count of inflammatory/non-inflammatory lesions | + | + | + | + |
Blood tests (AST, ALT, creatinine, serum cortisol, serum DHEA-S) | + | + | ||
Urine pregnancy test | + | + | + | |
Digital infrared thermal imaging | + | + | + | |
Randomization & allocation | + | |||
Distribution of treatment or placebo | + | + | ||
Visual analogue scale | + | + | + | |
Investigator Global Assessments | + | + | + | |
Korean Acne Grading System | + | + | + | |
Pattern identification for acne | + | |||
Monitoring adverse events | + | + | ||
Compliance check | + | + | ||
Blinding check | + |